GERN
Price
$1.42
Change
+$0.03 (+2.16%)
Updated
Apr 24 closing price
Capitalization
904.42M
12 days until earnings call
LIANY
Price
$0.17
Change
-$0.02 (-10.53%)
Updated
Apr 24 closing price
Capitalization
18.91M
14 days until earnings call
Ad is loading...

GERN vs LIANY

Header iconGERN vs LIANY Comparison
Open Charts GERN vs LIANYBanner chart's image
Geron
Price$1.42
Change+$0.03 (+2.16%)
Volume$5.33M
Capitalization904.42M
LianBio
Price$0.17
Change-$0.02 (-10.53%)
Volume$20K
Capitalization18.91M
GERN vs LIANY Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. LIANY commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a StrongBuy and LIANY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GERN: $1.42 vs. LIANY: $0.17)
Brand notoriety: GERN and LIANY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 32% vs. LIANY: 127%
Market capitalization -- GERN: $904.42M vs. LIANY: $18.91M
GERN [@Biotechnology] is valued at $904.42M. LIANY’s [@Biotechnology] market capitalization is $18.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileLIANY’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • LIANY’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 5 TA indicator(s) are bullish.

  • GERN’s TA Score: 5 bullish, 3 bearish.

Price Growth

GERN (@Biotechnology) experienced а +11.81% price change this week, while LIANY (@Biotechnology) price change was -12.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

GERN is expected to report earnings on Aug 07, 2025.

LIANY is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($904M) has a higher market cap than LIANY($18.9M). LIANY YTD gains are higher at: -33.962 vs. GERN (-59.887).
GERNLIANYGERN / LIANY
Capitalization904M18.9M4,783%
EBITDA-154.85MN/A-
Gain YTD-59.887-33.962176%
P/E RatioN/AN/A-
Revenue77MN/A-
Total Cash407MN/A-
Total Debt122MN/A-
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERN
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQJ28.710.63
+2.24%
Invesco NASDAQ Next Gen 100 ETF
KROP10.050.21
+2.13%
Global X AgTech & Food Innovation ETF
XBOC29.320.50
+1.74%
Innovator US Eq Acclrtd 9 Bffr ETF™ Oct
IBDS24.150.08
+0.33%
iShares iBonds Dec 2027 Term Corp ETF
BCHG2.82-0.04
-1.40%
Grayscale Bitcoin Cash Trust (BCH)

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
+2.16%
SER - GERN
66%
Loosely correlated
+5.36%
LIANY - GERN
53%
Loosely correlated
-7.80%
VCYT - GERN
44%
Loosely correlated
+2.15%
MIRM - GERN
39%
Loosely correlated
+2.15%
NRIX - GERN
37%
Loosely correlated
-0.78%
More

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
-7.80%
SER - LIANY
69%
Closely correlated
+5.36%
GERN - LIANY
53%
Loosely correlated
+2.16%
TRML - LIANY
28%
Poorly correlated
-2.81%
OTLK - LIANY
23%
Poorly correlated
N/A
MTNB - LIANY
21%
Poorly correlated
+1.71%
More